Other Events ·
Dermata Therapeutics announced the anticipated launch date for its first commercial product, Tome Foundational…
DRMAWDermata Therapeutics, Inc.
Dermata Therapeutics announced the anticipated launch date for its first commercial product, Tome Foundational Treatment, via a press release on August 5, 2026. The company expects sales to begin on August 25, 2026, with early access for waitlisted customers. The treatment set consists of four once-weekly applications and will be sold exclusively online at www.tomeskincare.com for $178, equating to approximately $45 per treatment. This marks a strategic shift toward commercializing skincare products to accelerate the path to revenue generation. Dermata Therapeutics operates in the dermatology and consumer healthcare industry, developing and marketing topical treatments for skin conditions.